Newronika Competitors and Similar CompaniesClear all
Newronika's competitors and similar companies include Kymab.
 Newronika Newronika develops neuromodulation therapies created to restores brain and body functioning. |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | |
Founding Date | Founding Date 2008 | Founding Date 2009 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Milano, IT HQ Cologno Monzese, IT Minneapolis, US | Locations Cambridge, GB HQ |
Employees | Employees 26 | Employees 407% decrease |
Funding | ||
Latest funding round | Latest funding round $ 9.2m (over 6 years ago) | Latest funding round $ 100m (over 9 years ago) |
Total funding raised | Total funding raised $ 11.2m | Total funding raised $ 220.4m |
For sources of this data, please see the company profile
View Company Profiles
Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company